Your browser doesn't support javascript.
loading
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Caffo, Orazio; Ortega, Cinzia; Nolè, Franco; Gasparro, Donatello; Mucciarini, Claudia; Aieta, Michele; Zagonel, Vittorina; Iacovelli, Roberto; De Giorgi, Ugo; Facchini, Gaetano; Veccia, Antonello; Palesandro, Erica; Verri, Elena; Buti, Sebastiano; Razzini, Giorgia; Bozza, Giovanni; Maruzzo, Marco; Ciccarese, Chiara; Schepisi, Giuseppe; Rossetti, Sabrina; Maines, Francesca; Kinspergher, Stefania; Fratino, Lucia; Ermacora, Paola; Nicodemo, Maurizio; Giordano, Monica; Sartori, Donata; Scapoli, Daniela; Sabbatini, Roberto; Lo Re, Giovanni; Morelli, Franco; D'Angelo, Alessandro; Vittimberga, Isabella; Lippe, Paolo; Carrozza, Francesco; Messina, Caterina; Galli, Luca; Valcamonico, Francesca; Porta, Camillo; Pappagallo, Giovanni; Aglietta, Massimo.
Afiliación
  • Caffo O; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy. Electronic address: orazio.caffo@apss.tn.it.
  • Ortega C; Department of Oncology, University of Turin Candiolo Cancer Institute - FPO-IRCCS, Candiolo, Italy.
  • Nolè F; Division of Urogenital and Head and Neck Tumours Medical Treatment, European Institute of Oncology IRCCS, Milan, Italy.
  • Gasparro D; Medical Oncology Unit, Department of General & Specialistic Medicine, University Hospital of Parma, Parma, Italy.
  • Mucciarini C; Medical Oncology Unit, Ramazzini Hospital, Carpi, Italy.
  • Aieta M; Department of Onco-Hematology, Division of Medical Oncology, IRCCS Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy.
  • Zagonel V; Department of Oncology, Oncology 1, Veneto Institute of Oncology - IRCCS, Padua, Italy.
  • Iacovelli R; Department of Medical Oncology, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy.
  • De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura de Tumori (IRST) IRCCS, Meldola, Italy.
  • Facchini G; Departmental Unit of Clinical and Experimental Uro-Andrologic Oncology, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy.
  • Veccia A; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.
  • Palesandro E; Department of Oncology, University of Turin Candiolo Cancer Institute - FPO-IRCCS, Candiolo, Italy.
  • Verri E; Division of Urogenital and Head and Neck Tumours Medical Treatment, European Institute of Oncology IRCCS, Milan, Italy.
  • Buti S; Medical Oncology Unit, Department of General & Specialistic Medicine, University Hospital of Parma, Parma, Italy.
  • Razzini G; Medical Oncology Unit, Ramazzini Hospital, Carpi, Italy.
  • Bozza G; Department of Onco-Hematology, Division of Medical Oncology, IRCCS Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy.
  • Maruzzo M; Department of Oncology, Oncology 1, Veneto Institute of Oncology - IRCCS, Padua, Italy.
  • Ciccarese C; Department of Medical Oncology, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy.
  • Schepisi G; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura de Tumori (IRST) IRCCS, Meldola, Italy.
  • Rossetti S; Departmental Unit of Clinical and Experimental Uro-Andrologic Oncology, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy.
  • Maines F; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.
  • Kinspergher S; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.
  • Fratino L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Ermacora P; Department of Oncology, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Azienda Sanitaria Universitaria Integrata Friuli Centrale, Udine, Italy.
  • Nicodemo M; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella, Italy.
  • Giordano M; Department of Medical Oncology, ASST Lariana, Ospedale Sant'Anna, San Fermo della Battaglia (CO), Italy.
  • Sartori D; Oncology Unit, AULSS 3, Mirano, Italy.
  • Scapoli D; Division of Clinical Oncology, S. Anna University Hospital, Ferrara, Italy.
  • Sabbatini R; Department of Oncology, Hematology & Respiratory Diseases, Division of Oncology, University of Modena & Reggio Emilia, Modena, Italy.
  • Lo Re G; Medical Oncology Department, Santa Maria degli Angeli Hospital, Pordenone, Italy.
  • Morelli F; Medical Oncology Department, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • D'Angelo A; Department of Medical Oncology, San Vincenzo Hospital, Taormina, Italy.
  • Vittimberga I; Dipartimento Oncologico, Ospedale Alessandro Manzoni, ASST Lecco, Lecco, Italy.
  • Lippe P; Operative Oncology Unit, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy.
  • Carrozza F; Oncology Unit, Ospedale "degli Infermi", AUSL Romagna, Faenza, Italy.
  • Messina C; Department of Medical Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Galli L; Department of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy.
  • Valcamonico F; Unit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy.
  • Porta C; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.
  • Pappagallo G; Clinical Epidemiologist, Silea, Italy.
  • Aglietta M; Department of Oncology, University of Turin Candiolo Cancer Institute - FPO-IRCCS, Candiolo, Italy.
Eur J Cancer ; 155: 56-63, 2021 09.
Article en En | MEDLINE | ID: mdl-34358777
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Feniltiohidantoína / Benzamidas / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Nitrilos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Feniltiohidantoína / Benzamidas / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Nitrilos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article